Clinical Trial Update: Neo-MASCT Immunotherapy for Advanced NSCLC. [Phase 1, Phase 2]

View source ↗

Summary

This entry reports an update on a Neo-MASCT immunotherapy trial for advanced non-small cell lung cancer (stage IV) in Phase 1 and Phase 2. The sponsor is The Fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Neo-MASCT immunotherapy

Snippet

Sponsor: The First People's Hospital of Lianyungang | Conditions: NSCLC Stage IV | Phase 1, Phase 2 | Status: UNKNOWN